Strand Diagnostics to Receive $30M Investment from Nantworks | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Strand Diagnostics today said it will receive an investment of $30 million from Nantworks to further grow the firm, scale its operational infrastructure, and expand sales and marketing efforts.

The funding will be provided over three years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.